Radiotherapy UK is delighted to welcome Ergéa as co-sponsor of Radiotherapy Daily, our popular weekday newsletter.
Ergéa will join long-term supporters Varian, in fronting the newsletter, which has a growing audience of more than 2,000 people from the radiotherapy community.
Ergéa is the leading service provider of Managed Equipment Services (MES) for the NHS and the private health sector in the UK. With more than 20 years of operational experience, its team brings a wealth of expertise and understanding to the challenges facing their clients in the UK and Ireland.
Ergéa also supports Radiotherapy UK’s work to support fair access to vital cancer treatment and recently sponsored our Travel Times report, which highlighted the 7.4million people unable to access life-saving radiotherapy within the recommended travel time. Meanwhile, Varian has a pioneering history in helping to advance radiotherapy, radiosurgery and many other vital cancer-fighting tools.
Charity Director, Sarah Quinlan MBE, said: “We warmly welcome Ergéa as co-sponsors of our Radiotherapy Daily. We are very proud to continue delivering such a popular and helpful guide into all things radiotherapy, with their support. We are also extremely grateful to the team at Varian for their long-term support of this resource. Our audience is growing and people tell us they love to have the newsletter in their inbox first thing every weekday. Thanks to the backing of Varian and Ergéa, we can keep this resource free and frequent.”
Tom Jacques, Business Development Manager for Ergéa, said: “Ergéa is thrilled to co-sponsor the Radiotherapy UK newsletter. We deeply admire the great work Radiotherapy UK is doing to support the radiotherapy community and advance cancer treatment. Through our innovative Managed Equipment Services (MES), we are committed to enhancing patient care and driving forward the future of radiotherapy in the UK. Together, we can make a significant impact on the lives of patients and the healthcare professionals who serve them.”
Sign up for the newsletter here
